Both in Pharmaceuticals
Capricor Therapeutics vs Climb Bio
Over the past year CAPR returned +47.2% and CLYM returned +396.3%; their daily moves had a correlation of 0.15.
CAPR +47.2% CLYM +396.3%Growth of $1, one year, split-adjusted
| Metric | CAPR | CLYM |
|---|---|---|
| Price | $8.92 | $9.33 |
| Market cap | $518.6M | $535.9M |
| Today | +8.25% | −4.31% |
| 1 month | +15.1% | −12.6% |
| 6 months | −74.1% | −23.6% |
| Year to date | −69.1% | +133.3% |
| 1 year | — | +366.5% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $237.9M | $183.1M |
| Dividend yield | — | — |
| Volatility (60d) | 144.1% | 80.8% |
| Short % of float | 48.4% | 25.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).